Copper Photocatalyzed Divergent Access to Organic Thio- and Isothiocyanates
ACS Catalysis · 2024-04-05 · 14 (7) · 4847-4855
DOI: 10.1021/acscatal.4c00565 ↗At a glance
Journal article in ACS Catalysis, published online on 2024-03-16. Written by Youssef Abderrazak and 1 co-authors. Cited 29 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.
Abstract (original language)
: We disclose a copper-photocatalyzed strategy that enables selective access to organic thiocyanates and isothiocyanates using benzylic thiocyanates as ATRA reagents. The electronic nature of the aromatic system is a crucial factor defining the outcome of the reaction for forging either the kinetic C − S or the thermodynamic C − N bonds. Mechanistic investigations support a radical pathway initiated by a reductive C − S bond cleavage of the substrates followed by a divergent inner-/outer-sphere interaction with copper depending on the electronic density of the formed intermediates. The developed protocol proceeds with high regio-and chemoselectivity and can also be applied for late-stage functionalization of bioactive molecules. The utility of the products is highlighted by their facile conversion to several building blocks that are relevant to organic synthesis.
Funding
- Deutsche Forschungsgemeinschaft
Cite
APA
Abderrazak, Y., & Reiser, O. (2024). Copper Photocatalyzed Divergent Access to Organic Thio- and Isothiocyanates. ACS Catalysis, 14(7), 4847-4855. https://doi.org/10.1021/acscatal.4c00565
Vancouver
Abderrazak Y, Reiser O. Copper Photocatalyzed Divergent Access to Organic Thio- and Isothiocyanates. ACS Catalysis. 2024;14(7):4847-4855. doi:10.1021/acscatal.4c00565
BibTeX
@article{Abderrazak2024,
author = {Abderrazak, Youssef and Reiser, Oliver},
title = {Copper Photocatalyzed Divergent Access to Organic Thio- and Isothiocyanates},
journal = {ACS Catalysis},
year = {2024},
volume = {14},
number = {7},
pages = {4847--4855},
doi = {10.1021/acscatal.4c00565}
}
EUVIMED